The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.67	33.49	14.01	114.3	6
Short-Term Investments	-	49.37	59.8	-	-
Cash & Short-Term Investments	49.67	82.86	73.81	114.3	6
Cash Growth	-40.05%	12.26%	-35.43%	1805.62%	145.20%
Accounts Receivable	48.34	42.36	39.82	20.01	17.15
Other Receivables	0.35	0.55	0.62	1.24	0.11
Receivables	48.68	42.91	40.43	21.24	17.26
Inventory	10.04	13.68	9.26	6.44	4.35
Prepaid Expenses	4.03	4.05	6.92	11.2	2.11
Restricted Cash	-	-	-	0.88	-
Total Current Assets	112.42	143.49	130.42	154.06	29.72
Property, Plant & Equipment	37.67	40.05	33.04	4.19	2.1
Long-Term Investments	-	-	58.35	-	-
Goodwill	7.23	7.23	21.42	26.63	14.23
Other Intangible Assets	14.81	17.9	17.96	18.25	19.52
Other Long-Term Assets	0.59	0.56	0.48	0.32	0.12
Total Assets	172.72	209.24	261.67	203.44	65.69
Accounts Payable	24.32	14.43	9.37	15.56	12.64
Accrued Expenses	13.01	10.7	9.42	8.33	4.21
Current Portion of Long-Term Debt	-	-	-	0.18	5.37
Current Portion of Leases	6.8	6.36	5.5	-	-
Current Income Taxes Payable	-	-	0.26	0.13	1.14
Current Unearned Revenue	4.7	1.09	1.14	0.26	3.38
Other Current Liabilities	3.38	2.21	4.04	5.33	1.86
Total Current Liabilities	52.22	34.79	29.72	29.8	28.61
Long-Term Debt	93.13	86.83	80.62	-	6.56
Long-Term Leases	23.22	26.49	22.06	-	-
Long-Term Deferred Tax Liabilities	0.03	0.03	0.11	0.37	1.61
Other Long-Term Liabilities	0.53	4.08	5.98	69.11	0.81
Total Liabilities	169.13	152.22	138.49	99.28	37.59
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	215.41	204.19	186.25	167.39	80.4
Retained Earnings	-210.81	-146.15	-63.08	-63.23	-52.31
Treasury Stock	-1.02	-1.02	-	-	-
Total Common Equity	3.59	57.03	123.18	104.16	28.1
Shareholders' Equity	3.59	57.03	123.18	104.16	28.1
Total Liabilities & Equity	172.72	209.24	261.67	203.44	65.69
Total Debt	123.15	119.68	108.18	0.18	11.93
Net Cash (Debt)	-73.48	-36.82	-34.37	114.12	-5.93
Net Cash Per Share	-0.98	-0.50	-0.43	1.72	-0.10
Filing Date Shares Outstanding	75.75	74.31	74.55	73.25	-
Total Common Shares Outstanding	75.74	74.15	73.27	73.25	-
Working Capital	60.2	108.71	100.7	124.26	1.11
Book Value Per Share	0.05	0.77	1.68	1.42	-
Tangible Book Value	-18.45	31.89	83.8	59.29	-5.64
Tangible Book Value Per Share	-0.24	0.43	1.14	0.81	-
Machinery	6.05	5.84	3.88	2.11	1.21
Construction In Progress	0.11	1.8	1.14	0.52	0.21
Leasehold Improvements	12.5	9.21	6.66	3.39	1.69

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q